Insulin glargine and lixisenatide and Ustekinumab Subcutaneous
Determining the interaction of Insulin glargine and lixisenatide and Ustekinumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Ustekinumab Subcutaneous Injection
- Insulin glargine and lixisenatide-Ustell
- Insulin glargine and lixisenatide-UTA
- Insulin glargine and lixisenatide-UTA Capsules
- Insulin glargine and lixisenatide-UTAC tablets
- Insulin glargine and lixisenatide-UTI Relief
- Ustekinumab Subcutaneous-Insulin glargine and lixisenatide Subcutaneous
- Ustekinumab Subcutaneous-Insulin glargine, recombinant Subcutaneous
- Ustekinumab Subcutaneous-Insulin glulisine
- Ustekinumab Subcutaneous-Insulin Glulisine (Cartridges and Pens)
- Ustekinumab Subcutaneous-Insulin Glulisine (Vials)
- Ustekinumab Subcutaneous-Insulin glulisine Subcutaneous